MX9305453A - Metodo para tratar infecciones virales. - Google Patents

Metodo para tratar infecciones virales.

Info

Publication number
MX9305453A
MX9305453A MX9305453A MX9305453A MX9305453A MX 9305453 A MX9305453 A MX 9305453A MX 9305453 A MX9305453 A MX 9305453A MX 9305453 A MX9305453 A MX 9305453A MX 9305453 A MX9305453 A MX 9305453A
Authority
MX
Mexico
Prior art keywords
viral infections
treating viral
oso3
responds
substance
Prior art date
Application number
MX9305453A
Other languages
English (en)
Inventor
Carl Franz De Vos Albrecht
Roelof Wilkw Liebenberg
Petrus Bys Kruger
Patrick Jacques Desire Bouic
Original Assignee
Virostat Na Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virostat Na Nv filed Critical Virostat Na Nv
Publication of MX9305453A publication Critical patent/MX9305453A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/205Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings
    • C07C39/21Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings with at least one hydroxy group on a non-condensed ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • C07H1/08Separation; Purification from natural products
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La invención se refiere con la preparación de una sustancia para el tratamiento de infecciones virales que responde a la fórmula general (1): en donde R1, R2, R3, Y R4, son iguales o diferentes entre sí y se seleccionan entre -H, -OH, A, B, C, Y D, donde : cualquiera de los 1-3 de los grupos -OSO3 está sustituido opcionalmente con -OH.
MX9305453A 1992-09-07 1993-09-06 Metodo para tratar infecciones virales. MX9305453A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA926775 1992-09-07
ZA933949 1993-06-04

Publications (1)

Publication Number Publication Date
MX9305453A true MX9305453A (es) 1994-05-31

Family

ID=66817979

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9305453A MX9305453A (es) 1992-09-07 1993-09-06 Metodo para tratar infecciones virales.

Country Status (10)

Country Link
EP (1) EP0587396A1 (es)
JP (1) JPH06219974A (es)
KR (1) KR940006591A (es)
CN (1) CN1091291A (es)
AU (1) AU667564B2 (es)
BR (1) BR9303733A (es)
CA (1) CA2105630A1 (es)
IL (1) IL106939A0 (es)
MX (1) MX9305453A (es)
ZW (1) ZW11693A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5569649A (en) * 1994-06-14 1996-10-29 Phytopharm (Na) N.V. Anti-inflammatory treatment method
WO2013112780A1 (en) * 2012-01-26 2013-08-01 Life Technologies Corporation Methods for increasing the infectivity of viruses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2120650A (en) * 1982-04-19 1983-12-07 Roecar Holdings Nv Rooperol derivatives
GB8317850D0 (en) * 1983-06-30 1983-08-03 Roecar Holdings Nv Rooperol and its derivatives
JPS6242942A (ja) * 1985-06-19 1987-02-24 ロ−ペロ−ル(エヌア−)エヌフアウ ル−ペロ−ルの製造法

Also Published As

Publication number Publication date
ZW11693A1 (en) 1994-03-30
KR940006591A (ko) 1994-04-25
JPH06219974A (ja) 1994-08-09
AU4611093A (en) 1994-03-17
BR9303733A (pt) 1994-03-15
CN1091291A (zh) 1994-08-31
AU667564B2 (en) 1996-03-28
CA2105630A1 (en) 1994-03-08
IL106939A0 (en) 1993-12-28
EP0587396A1 (en) 1994-03-16

Similar Documents

Publication Publication Date Title
ATE269290T1 (de) Benzoylderivate
DE69200685T2 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3-Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten.
MX9400206A (es) Derivados de vinil-azaindol, proceso para su preparacion y composiciones farmaceuticas que los contienen.
DK249389A (da) 2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer
DE3576328D1 (de) Behandlung feuerfester gegenstaende.
DE69019533T2 (de) Behandlung von hiv-infizierungen und nützliche verbindungen dafür.
ES2052961T3 (es) Compuestos de fosfonio con actividad biocida.
ES2156120T3 (es) Derivados arilamidicos.
PT100357A (pt) Compostos lactama macrociclicos, seu processo de preparacao e intermediarios, e composicoes que os contem
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
FI891986A (fi) Farmaceutiska sammansaettningar foer behandling av psoriasis.
ATE61044T1 (de) Insektizide n-(gegebenenfalls substituierte)-n'substituierte-n,n'-disubstituierte hydrazine.
ES2157899T3 (es) Derivados de sampangina utiles como agentes antifungicos y antimicobacterianos.
MX9305453A (es) Metodo para tratar infecciones virales.
MX9301863A (es) Morfolin y tiomorfolin 4-ilamidas
ATE69220T1 (de) Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen.
AR004484A1 (es) Nuevas 1,2,3,4-tetrahidro-2-naftalenaminas fenilo-sustituidas en el anillo aromatico, su preparacion, sus aplicaciones terapeuticas y las composicionesfarmaceuticas que las contienen.
DE336374T1 (de) Behandlung von zusammensetzungen von polyimid-vorlaeufern.
DE59207900D1 (de) Iloprost mit wirkung gegen cerebrale malaria
NO175856C (no) Analogifremgangsmåte for fremstilling av nye - og fucosidase-inhibitorer
MX9300008A (es) Nucleosidos terapeuticos.
ES2003063A4 (es) Derivados de pirrolidin-2-ona, que tengan actividad nootropica.
FI915801A (fi) Komposition och foerfarande foer att foerhindra fluoros.
ES2076248T3 (es) Dibenzofuranos substituidos y metodos para el uso de los mismos.
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.